Executive Director, Investor Relations
Entrada TherapeuticsBoston, Massachusetts, United States
Posted March 12, 2026
292000 - 395000 USD
Full Time
About the Company
Entrada Therapeutics is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible.
Job Description
Entrada Therapeutics is a clinical-stage biopharmaceutical company looking for an Executive Director, Investor Relations to develop and execute a comprehensive investor relations strategy. The ideal candidate will combine deep investor relations and financial expertise with strong scientific and clinical fluency to build investor confidence, drive awareness, and support long-term shareholder value creation for a NASDAQ-listed biotechnology company with an expanding portfolio of clinical-stage programs.
Requirements
- 10+ years of progressive experience in investor relations within the biotechnology or pharmaceutical industry.
- Experience supporting investor relations for a publicly traded biotechnology or pharmaceutical company, preferably NASDAQ-listed.
- Experience in a clinical-stage or pre-commercial biotechnology environment strongly preferred.
- Established relationships within the biotechnology buy-side and sell-side community strongly preferred.
- Strong financial acumen and financial modeling familiarity, with the ability to clearly communicate complex financial and clinical information to diverse external stakeholders.
Benefits
- Comprehensive health, dental and vision coverage
- Life and disability insurance
- 401(k) match
- Paid, gender-inclusive parental leave
- Holistic support for your health and well-being
- Education reimbursement
- Discretionary time off and commuting benefits aligned to your working model
